Advanced Asset Management Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-145,145
Closed -$4.03M 92
2024
Q1
$4.03M Hold
145,145
1% 39
2023
Q4
$4.18M Sell
145,145
-201
-0.1% -$6.08K 0.99% 38
2023
Q3
$4.82M Sell
145,346
-180
-0.1% -$6.37K 1.16% 33
2023
Q2
$5.34M Sell
145,526
-188
-0.1% -$7.32K 1.24% 33
2023
Q1
$5.95M Buy
145,714
+2
+0% +$86 1.45% 26
2022
Q4
$7.47M Buy
145,712
+1
+0% +$48 1.87% 18
2022
Q3
$6.38M Buy
145,711
+2
+0% +$97 1.75% 21
2022
Q2
$7.64M Buy
145,709
+1
+0% +$51 1.96% 15
2022
Q1
$7.54M Sell
145,708
-435
-0.3% -$22.6K 1.65% 24
2021
Q4
$8.63M Buy
146,143
+2
+0% +$99 1.79% 16
2021
Q3
$6.29M Sell
146,141
-117
-0.1% -$5.18K 1.35% 22
2021
Q2
$5.73M Sell
146,258
-432
-0.3% -$16.8K 1.21% 27
2021
Q1
$5.32M Buy
146,690
+4
+0% +$142 1.18% 29
2020
Q4
$5.4M Sell
146,686
-8,021
-5% -$294K 1.26% 25
2020
Q3
$5.39M Buy
154,707
+3
+0% +$105 1.43% 22
2020
Q2
$4.8M Buy
154,704
+82,846
+115% +$2.81M 1.41% 24
2020
Q1
$2.23M Buy
71,858
+4
+0% +$136 0.77% 43
2019
Q4
$2.67M Sell
71,854
-282
-0.4% -$10K 0.81% 41
2019
Q3
$2.46M Buy
72,136
+1,426
+2% +$51.9K 0.79% 39
2019
Q2
$2.91M Buy
70,710
+214
+0.3% +$8.5K 1.01% 28
2019
Q1
$2.84M Sell
70,496
-129
-0.2% -$5.17K 1.01% 26
2018
Q4
$2.92M Buy
+70,625
New +$2.93M 0.94% 28
2018
Q3
Sell
-70,620
Closed -$2.43M 116
2018
Q2
$2.43M Buy
70,620
+22,032
+45% +$753K 0.78% 23
2018
Q1
$1.64M Buy
48,588
+2
+0% +$69 0.54% 41
2017
Q4
$1.67M Buy
+48,586
New +$1.66M 0.55% 41

Other funds holding PFE

Advanced Asset Management Advisors's PFE Position: Q2 2024 in Review

Advanced Asset Management Advisors sold out of Pfizer (PFE) in Q2 2024, closing a stake of 145,145 shares — an estimated $4.03M sold.

Advanced Asset Management Advisors first reported a position in PFE in Q4 2017 and held it in 25 quarters. The position peaked at $8.63M in Q4 2021. 2,873 funds tracked by Wall St. Rank hold PFE as of Q2 2024.

  • Advanced Asset Management Advisors reported no remaining Pfizer position as of Q2 2024 after selling out during the quarter.
  • Advanced Asset Management Advisors sold 145,145 Pfizer shares in Q2 2024, an estimated $4.03M.
  • Advanced Asset Management Advisors first reported a position in Pfizer in Q4 2017 and held it in 25 quarters.
  • Advanced Asset Management Advisors's Pfizer position peaked at $8.63M in Q4 2021.
  • 2,873 funds tracked by Wall St. Rank held Pfizer as of Q2 2024.

Based on Advanced Asset Management Advisors's 13F filing for Q2 2024, filed 1 Aug 2024.